Phase II study of paclitaxel in patients with soft tissue sarcomas

By Patel Shreyaskumar R.   Linke Kaye A.   Burgess M. Andrew   Papadopoulos Nicholas E.   Plager Carl   Jenkins Jan   Benjamin Robert  

Sarcoma, Vol. 1, Iss. 2, 1997-06 ,pp. : 95-98

Informa Healthcare

Access to resources Recommend Favorite

Gemcitabine in advanced adult soft-tissue sarcomas. A phase II study of the EORTC Soft Tissue and Bone Sarcoma Group

By Svancarova L.   Blay J.Y.   Judson I.R.   van Hoesel Q.G.C.M.   van Oosterom A.T.   le Cesne A.   Keizer H.J.   Hermans C.   van Glabbeke M.   Verweij J.   Hogendoorn P.C.W.   Nielsen O.S.  

European Journal of Cancer, Vol. 38, Iss. 4, 2002-03 ,pp. : 556-559

Elsevier

Access to resources Recommend Favorite

Effect of high-dose ifosfamide in advanced soft tissue sarcomas. A multicentre phase II study of the EORTC Soft Tissue and Bone Sarcoma Group - is it feasible?

By Nielsen O.S.   Judson I.   van Hoesel Q.   le Cesne A.   Keizer H.J.   Blay J.Y.   van Oosterom A.   Radford J.A.   Svancarova L.   Krzemienlecki K.   Hermans C.   van Glabbeke M.   Oosterhuis J.W.   Verweij J.  

European Journal of Cancer, Vol. 36, Iss. 1, 2000-01 ,pp. : 61-67

Elsevier

Access to resources Recommend Favorite

A phase II study of docetaxel and epirubicin in advanced adult soft tissue sarcomas (STS)

By Kalofonos Haralabos P.  

Sarcoma, Vol. 8, Iss. 4, 2004-12 ,pp. : 129-133

Informa Healthcare

Access to resources Recommend Favorite

Phase II prospective study with sorafenib in advanced soft tissue sarcomas after anthracycline-based therapy

By Santoro A.   Comandone A.   Basso U.   Soto Parra H.   De Sanctis R.   Stroppa E.   Marcon I.   Giordano L.   Lutman F. R.   Boglione A.   Bertuzzi A.  

Annals of Oncology, Vol. 24, Iss. 4, 2013-04 ,pp. : 1093-1098

Oxford University Press

Access to resources Recommend Favorite